Lortab and Conjunctivitis exacerbated - a phase IV clinical study of FDA data

Summary:

Conjunctivitis exacerbated is reported as a side effect among people who take Lortab (acetaminophen; hydrocodone bitartrate), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Aredia, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Conjunctivitis exacerbated when taking Lortab. It is created by eHealthMe based on reports of 29,547 people who have side effects when taking Lortab from the FDA, and is updated regularly.

What is Lortab?

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 31,285 Lortab users. Check the latest studies of Lortab.

What is Conjunctivitis exacerbated?

Conjunctivitis exacerbated (bad situation of conjunctivitis) is found to be associated with 1,068 drugs and 426 conditions by eHealthMe. Check the latest studies of Conjunctivitis exacerbated.

On Jul, 14, 2026

29,547 people reported to have side effects when taking Lortab.
Among them, 74 people (0.25%) have Conjunctivitis exacerbated.

Could Lortab cause Conjunctivitis exacerbated?

Among these 74 people:

How long have people been on Lortab when they have Conjunctivitis exacerbated? *

What is the gender of people who have Conjunctivitis exacerbated when taking Lortab? *

female: 89.19 %
male: 10.81 %

What is the age of people who have Conjunctivitis exacerbated when taking Lortab? *

What are other drugs people take besides Lortab? *

What are other side effects people have besides Conjunctivitis exacerbated? *

Stress And Anxiety: 41 people, 55.41%
Depression: 35 people, 47.30%
Weakness: 30 people, 40.54%
Anaemia (lack of blood): 29 people, 39.19%
Injury: 29 people, 39.19%
Headache (pain in head): 29 people, 39.19%
Urinary Tract Infection: 28 people, 37.84%
Rashes (redness): 27 people, 36.49%
Osteopenia (a condition where bone mineral density is lower than normal): 27 people, 36.49%
Osteonecrosis Of Jaw (death of bone of jaw): 26 people, 35.14%

What are the existing conditions these people have? *

Stress And Anxiety: 11 people, 14.86%
Metastases To Bone (cancer spreads to bone): 10 people, 13.51%
Erythema Nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below): 6 people, 8.11%
Leukocytoclastic Vasculitis (inflammation of small blood vessels (usually post-capillary venules in the dermis), characterized by palpable purpura): 6 people, 8.11%
Staphylococcal Infection (an infection with staphylococcus bacteria): 6 people, 8.11%
Behcet's Syndrome (involves inflammation of the blood vessels): 6 people, 8.11%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 6.76%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 5.41%
Depression: 3 people, 4.05%
High Blood Pressure: 3 people, 4.05%

* Approximation only. Some reports may have incomplete information.

Do you take Lortab and have Conjunctivitis exacerbated?

- Check whether Conjunctivitis exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lortab:

Lortab (31,285 reports)

Conjunctivitis exacerbated treatments and more:

Conjunctivitis exacerbated (5 reports)

How severe was Conjunctivitis exacerbated and when was it recovered:

Conjunctivitis exacerbated in Lortab

Expand to all the drugs that have ingredients of acetaminophen; hydrocodone bitartrate:

Conjunctivitis exacerbated and drugs with ingredients of acetaminophen; hydrocodone bitartrate (261 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lortab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (1,068 drugs)

Browse all the conditions that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (426 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate (the active ingredients of Lortab) and Lortab (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.